Back to results
US 7,981,999 B2Granted
Triazole macrocycle systems
AssigneeAileron Therapeutics, Inc.
InventorHuw M. Nash
Life of this patent
Estimating the term…
Abstract
The present invention provides novel peptidomimetic macrocycles and methods for their preparation and use, as well as amino acid analogs and macrocycle-forming linkers, and kits useful in their production. In various embodiments, the peptidomimetic macrocycles are of Formula I: The linker L includes a triazole moiety. Peptidomimetic macrocycles according to the invention may exhibit increased α-helical or beta sheet structure in aqueous solution compared to a corresponding non-macrocyclic polypeptide.
Claims59
A peptidomimetic macrocycle of Formula (I):
- wherein:
- each A, C, D, and E is independently a natural or non-natural amino acid;
- B is a natural or non-natural amino acid, amino acid analog,
- [—NH-L3-CO—], [—NH-L3-SO2—], or [—NH-L3-];
- R1 and R2 are independently —H, alkyl, alkenyl, alkynyl, arylalkyl, cycloalkyl, cycloalkylalkyl, heteroalkyl, or heterocycloalkyl, each non-H group being optionally substituted with halo-;
- R3 is hydrogen, alkyl, alkenyl, alkynyl, arylalkyl, heteroalkyl, cycloalkyl, heterocycloalkyl, cycloalkylalkyl, cycloaryl, or heterocycloaryl, each non-H group being optionally substituted with R5;
- L is a macrocycle-forming linker of the formula
- L1, L2 and L3 are independently alkylene, alkenylene, alkynylene, heteroalkylene, cycloalkylene, heterocycloalkylene, cycloarylene, heterocycloarylene, or [—R4—K—R4—]n, each being optionally substituted with R5;
- each R4 is alkylene, alkenylene, alkynylene, heteroalkylene, cycloalkylene, heterocycloalkylene, arylene, or heteroarylene;
- each K is O, S, SO, SO2, CO, C(═O)—O—, or CONR3;
- each R5 is independently halogen, alkyl, —OR6, —N(R6)2, —SR6, —SOR6, —SO2R6, —CO2R6, a fluorescent moiety, a radioisotope or a therapeutic agent;
- each R6 is independently —H, alkyl, alkenyl, alkynyl, arylalkyl, cycloalkylalkyl, heterocycloalkyl, a fluorescent moiety, a radioisotope or a therapeutic agent;
- R7 is —H, alkyl, alkenyl, alkynyl, arylalkyl, cycloalkyl, heteroalkyl, cycloalkylalkyl, heterocycloalkyl, cycloaryl, or heterocycloaryl, each non-H group being optionally substituted with R5, or part of a cyclic structure with a D residue;
- R8 is —H, alkyl, alkenyl, alkynyl, arylalkyl, cycloalkyl, heteroalkyl, cycloalkylalkyl, heterocycloalkyl, cycloaryl, or heterocycloaryl, each non-H group being optionally substituted with R5, or part of a cyclic structure with an E residue;
- v is an integer from 1-1000;
- w is an integer from 1-1000;
- x is an integer from 0-10;
- y is an integer from 0-10;
- z is an integer from 0-10;
- and
- n is an integer from 1-5;
- wherein the peptidomimetic macrocycle comprises an α-helix or beta sheet.
19 more elements
Dependencies are inferred from the claim text.